Cargando…
Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
BACKGROUND: Oseltamivir-resistant mutants with higher drug resistance rates and low trans-mission fitness costs have not accounted for influenza (sub)type viruses. Predicting the impacts of neuraminidase inhibitor therapy on infection rates and transmission of drug-resistant viral strains requires f...
Autores principales: | Hsieh, Nan-Hung, Lin, Yi-Jun, Yang, Ying-Fei, Liao, Chung-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529381/ https://www.ncbi.nlm.nih.gov/pubmed/28790857 http://dx.doi.org/10.2147/IDR.S138317 |
Ejemplares similares
-
Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010) -
Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009) -
A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes
por: van den Dool, Carline, et al.
Publicado: (2009) -
Mathematical modeling of postcoinfection with influenza A virus and Streptococcus pneumoniae, with implications for pneumonia and COPD-risk assessment
por: Cheng, Yi-Hsien, et al.
Publicado: (2017) -
Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)